cytena received EUR 1.1 million

Seed capital from HTGF and a private investor



cy-Clone, Photo: cytena GmbH

cytena GmbH, a spin-off of the Laboratory for MEMS Applications (Prof. Dr. Roland Zengerle) , has developed a device called cy-Clone to separate single cells. cytena’s newest innovation enables the gentle separation of cells. A consortium made up of a private investor and High-Tech Gründerfonds (HTGF), will provide EUR 1.1 million of seed capital. cytena GmbH will use this capital injection primarily to launch its product and to expand its marketing and distribution activities.For the past four years, Jonas Schöndube, André Gross and Dr. Peter Koltay have been focussing on single-cell printing technologies. They partnered with the economist Benjamin Steimle and BioFluidix GmbH to found cytena, a University of Freiburg spin-off company in 2014.



Benjamin Steimle
Technische Fakultät
Albert-Ludwigs-Universität Freiburg
Tel.: 0761/203-73219
E-Mail: steimle(at)

Dr. Thomas Maier
Albert-Ludwigs-Universität Freiburg
Tel.: 0761/203-5212
E-Mail: thomas.maier(at)


Benutzerspezifische Werkzeuge